# CNS Pharmaceuticals, Inc.: Form 8-K, filed Mar 31, 2025

- Company: [CNS Pharmaceuticals, Inc.](/companies/cnsp.md) (CIK 1729427)
- Form: 8-K
- Filed: 2025-03-31
- Accepted by EDGAR: Mar 31, 2025, 21:12 ET
- Period: 2025-03-31
- Accession: 0001683168-25-002140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825002140/cns_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729427/000168316825002140/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729427/000168316825002140/cns_8k.htm

Filed Mar 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-002140. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.